Previous studies have demonstrated that Trop2 promotes tumor progression, metastasis and therapy resistance through multiple signaling pathways including ERK/MAPK15, PI3K/AKT16, and Wnt/β-catenin.17 The gene discussed is TACSTD2; the disease is neoplasm.